ClinicalTrials.gg
Sign In
RecruitingNCT05456919BRCA_SFQ28Updated Jul 13, 2022

Quality of Sexual Function in BRCA Mutated Women

An observational study in BRCA Mutation, Sexual Dysfunction and Sexual Dysfunctions, Psychological, sponsored by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia. Recruiting at 1 site in Italy. Open to female participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2022-07-13.

Sponsored by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · Observational

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
300
Ages
18 Years to 99 Years
Sex
Female
01

Study summary

Quality of sexual function in BRCA mutated women is investigated using SFQ28 questionnaire.

Read the detailed description

We aim to investigate and compare the impact of diagnosis of BRCA, the impact of risk reducing surgery (RRS) and oncological diagnosis.

02

Conditions studied

  • BRCA Mutation
  • Sexual Dysfunction
  • Sexual Dysfunctions, Psychological
  • Sexual Dysfunction, Physiological

Keywords

  • brca
  • sexual
03

In context

Sexual Dysfunction, Physiological

385 studies on the registry are indexed under Sexual Dysfunction, Physiological; 72 are open to participants now.

This study's planned enrollment of 300 is above the median of 176 across 113 observational studies indexed under Sexual Dysfunction, Physiological.

Browse Sexual Dysfunction, Physiological studies →

Lead sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia is the lead sponsor of 84 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

TBC

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • TBC

Exclusion criteria

Exclusion Criteria:

  • TBC
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • BRCA Mutated and no RRS

    Other: SFQ28 Questionnaire

  • BRCA Mutated and RRS

    Other: SFQ28 Questionnaire

  • BRCA Mutated and oncological diagnosis

    Other: SFQ28 Questionnaire

  • BRCA Wildtype without oncological diagnosis

    Other: SFQ28 Questionnaire

Interventions

  • OtherSFQ28 Questionnaire

    SFQ28 Questionnaire

06

What researchers measure

Primary outcomes

  1. Measurement of SFQ28 Score

    Time frame: At enrollment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05456919
Lead sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Responsible party
Federico Ferrari (Research Associate, Università degli Studi di Brescia) — Principal investigator
First posted
Jul 13, 2022
Start date
Jul 15, 2022 (estimated)
Primary completion
Jul 15, 2024 (estimated)
Completion
Jul 15, 2025 (estimated)
Last update
Jul 13, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Sexual Dysfunction, Physiological →

Other studies from this sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Start the discussion